Invesco »

An2 Therapeutics shares owned by Invesco

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Invesco from 13F filings

Historical chart of Invesco investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Invesco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Invesco

Quarter filed Position value Share count Share price at filing
2026-06-30 $67k 14k 4.84
2023-12-31 $3.2M 158k 20.49
2023-09-30 $3.0M 188k 16.08

More positions owned by Invesco

NVIDIA Corporation (NVDA)
Apple (AAPL)
Micron Technology (MU)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Advanced Micro Devices (AMD)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Lam Research Corp Com New (LRCX)
Intel Corporation (INTC)
Meta Platforms Cl A (META)
Applied Materials (AMAT)
Wal-Mart Stores (WMT)

View all positions for Invesco

Top funds holding An2 Therapeutics

Vivo Capital
Commodore Capital
Millennium Management
BlackRock
Spruce Street Capital
Almitas Capital
Vanguard Capital Management
Adage Capital Partners GP
Citadel Advisors
Boxer Capital Management
Geode Capital Management
SummitTX Capital
Balyasny Asset Management
Stonepine Capital Management
Ameriprise Financial

View all funds holding An2 Therapeutics